Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.31 |
| ▸ | NPC1 | O15118 | 2/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | MAPT | P10636 | 2/20 | 0.31 |
| ▸ | RAB9A | P51151 | 2/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | STAT1 | P42224 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27666999 | 0.64 | BRD4 (0.31) | — | |
| SCHEMBL1706036 | 0.62 | BRD4 (0.34) | — | |
| SCHEMBL4974655 | 0.61 | MAPK1 (0.31) | ALDH1A1MAPK1 | |
| SCHEMBL18587803 | 0.61 | ALDH1A1 (0.32) | ALDH1A1GAA | |
| SCHEMBL3410698 | 0.61 | HTR6 (0.33) | — | |
| SCHEMBL6946328 | 0.60 | ALDH1A1 (0.33) | NPC1ALDH1A1MAPTRAB9AKMT2A | |
| SCHEMBL17338110 | 0.60 | ALDH1A1 (0.36) | NPC1ALDH1A1MAPTRAB9AKMT2A | |
| SCHEMBL5571914 | 0.60 | CA1 (0.30) | — | |
| SCHEMBL3413205 | 0.60 | — | — | |
| SCHEMBL1219320 | 0.58 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105732636-B | Heteroaromatic compounds and their use in medicine | 广东东阳光药业有限公司 | 2020-04-21 | — | — | CN | disclosed |
| WO-2009077874-A2 | A PHARMACEUTICAL COMPOSITION FOR TREATING ESOPHAGEAL CANCER | EISAI R & D MANAGEMENT CO., LTD. (US) | 2009-06-25 | — | — | WO | disclosed |